Anti-diabetic drug ‘Ayush-82’ to be commercialized

Developed by the New Delhi based Central Council for Research in Ayurvedic Sciences (CCRAS), the ayurvedic formulation for prevention and management of Diabetes will be brought to market by Kudos Laboratories India

0
1367
Download PDF
The MOU exchange between partner organizations.

New Delhi: The National Research Development Corporation (NRDC) of the Department of Scientific and Industrial Research, Ministry of Science & Technology signed a License Agreement with Kudos Laboratories India for commercialization of Ayush-82, an ayurvedic formulation for prevention and management of  Diabetes.

It has been developed by Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, an apex organization for research in Ayurveda under the Ministry of AYUSH (Ayurveda, Yoga & Naturopathy, Unani, Siddha and Homeopathy).

Chairman and Managing Director NRDC, Dr H Purushotham, Prof Vd. K S Dhiman, Director General of CCRAS and Senior Executives/Scientists of NRDC and CCRAS were also present during the event. Prof Dhiman highlighted about the formulation and its benefits. Dr H Purushotham said that patients are preferring Ayurvedic drugs as it can be seen that in the recent past NRDC licensed 12 Ayurvedic drugs developed by CCRAS to 32 companies in India.

Now Kudos Laboratories India could commercialize this product under their trade name with due acknowledgement to CCRAS, Ministry of AYUSH, Government of India.